[Code of Federal Regulations]

As the Agency approached the 25th anniversary of the last major revisions to the drug cGMP regulations, FDA recognized that it was time to step back and evaluate the currency of both the cGMP program and the pre-market review of chemistry and manufacturing issues. The Agency’s Pharmaceutical Quality Initiative builds upon the many successes ... ................
................